Home
Clementia Pharmaceuticals

Clementia Pharmaceuticals Market Share Analysis for June 2026

Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.

Health > Biotechnology and Pharmaceuticals

Domainclementiapharma.com

Year Founded2011

Employees5001 - 10000

Annual Revenue$5M - $10M

Clementia Pharmaceuticals

Clementia Pharmaceuticals (including company regionals)

clementiapharma.com

See more website traffic and engagement information

Clementia Pharmaceuticals Revenue up to June 2026 is 5M - 10M

revenue generated by Clementia Pharmaceuticals top domains

Clementia Pharmaceuticals top domains revenue over 3 years

Revenue for Clementia Pharmaceuticals top domains

clementiapharma.com5M - 10M

See more with Sales Intelligence

Total visits to Clementia Pharmaceuticals's top domains

Understand Clementia Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Clementia Pharmaceuticals's top domains

Analyze Clementia Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Clementia Pharmaceuticals's top domains

See how Clementia Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Clementia Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Clementia Pharmaceuticals

These are the website technologies, by industry, used by Clementia Pharmaceuticals top domains

Widget (6)

Twemoji

Social (4)

Instagram

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

More Technologies

8

See all

News & Signals from Clementia Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsClementiapharma acquired Epizyme on Dec 5th '22.Most recently, Clementiapharma acquired the biotech Epizyme.

NewsClementiapharma partners with BioLabs.“ Clementiapharma is proud to renew its long-standing partnership with Biolabs by becoming a founding sponsor of their first life science innovation hub in Europe, at the historical Hopital Hotel Dieu, AP-HP.

NewsClementiapharma launches Fleet for Future project.Clementiapharma launched its Fleet for Future project in 2021, which aims to reduce the GHG emissions of the fleet >40% by 2025.